Mainland China
Taoping Signs Non-binding Letter of Intent to Acquire Yunti; Transformational Acquisition Would Substantially Improve Taoping's Annual Revenue, Expand its Addressable Market, and Leverage its Current Portfolio
SHENZHEN, China, Dec. 9, 2024 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, new media and artificial intelligence (AI) solutions, today announced that it has signed a non-binding letter of intent to acquire 100% o...
Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that the National Medical Products Administration of...
U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025
Third-generation member of Thailand's Charoen Pokphand Group and Fortune magazine owner reinforces commitment to U Power's innovative EV battery solutions SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- U Power Limited (the "Company" or "U Power"), today announced a strategic meeting between CEO Jia Li a...
Noah Showcases Global Expansion and Investment Product Leadership at 2024 Corporate Open Day
* Accelerating global expansion into emerging markets with new brands * Global investment allocation strategies and expanded product offerings drive long-term value for clients * Expanding comprehensive service matrix to address evolving client needs globally SHANGHAI, Dec. 9, 2024 /PRNewswi...
Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting
DZD8586 demonstrated encouraging anti-tumor activity with manageable safety and favorable pharmacokinetic (PK) characteristics in patients with B-NHL SHANGHAI, Dec. 9, 2024 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment o...
iQIYI Introduces 'Extra Large Font' Function to Enhance Accessibility for Senior Users
BEIJING, Dec. 9, 2024 /PRNewswire/ -- iQIYI, China's leading online entertainment platform, recently launched a new 'Extra Large Font' function on its app, offering a comprehensive suite of accessibility features tailored for senior users and the visual requirements of a broader audience. With ju...
Hello Group Inc. Announces Unaudited Financial Results for the Third Quarter of 2024
BEIJING, Dec. 9, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading player in mainlandChina's online social networking space, today announced its unaudited financial results for the third quarter of 2024. Third Quarter of 2024 Highlights * Net r...
Global Times: Doctor and warrior: Chinese MMA fighter Shi Ming rises to fame for contrasting identities
BEIJING, Dec. 8, 2024 /PRNewswire/ -- After defeating her opponent Feng Xiaocan in a UFC tournament in the Macao Special Administrative Region in November, China's mixed martial arts (MMA) fighter Shi Ming solidified her reputation - not just through her athletic performance, but also for her iden...
The revival of Notre-Dame witnesses the value of cultural exchange and mutual learning: Global Times editorial
BEIJING, Dec. 8, 2024 /PRNewswire/ -- The restored Notre-Dame de Paris cathedral reopened on Sunday, following a grand ceremony held the day before. In his speech at the ceremony, French PresidentEmmanuel Macron expressed gratitude on behalf of the French people to "all those who saved, helped an...
2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting
SHANGHAI, Dec. 8, 2024 /PRNewswire/ -- December 8, 2024, Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versus-Host Disease (cGvHD) who have either progressed or not responded to one or mo...
Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH
BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024 ASH (Ame...
Nanning: A Colorful City of Cultural Diversity
BEIJING, Dec. 8, 2024 /PRNewswire/ -- A report from China Daily:
Global Times: Clay Figure Zhang's works naturally reflect spiritual state of the times
BEIJING, Dec. 7, 2024 /PRNewswire/ -- From exquisite craftsmanship to traditional Chinese medicine, from solemn rituals to vibrant folk art, intangible cultural heritage weaves the tapestry of Chinese identity. For centuries, the essential elements of intangible cultural heritage have been passe...
A new layer of unique significance is attached to Spring Festival: Global Times editorial
BEIJING, Dec. 7, 2024 /PRNewswire/ -- The Spring Festival, a Chinese cultural symbol that has long been well-known around the globe, has gained a new title this week. The United Nations Educational, Scientific and Cultural Organization (UNESCO) added "Spring Festival, social practices of the Chin...
Baijiayun Announces Up To $15 Million Convertible Promissory Notes And $50 Million Standby Equity Purchase Agreement
BEIJING, Dec. 6, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it has entered into a Standby Equity Purchase Agreement (the "SEPA"), with YA II PN, Ltd. ("YA"), a fund managed by Yorkville Advisor...
JXJT First Half Year Financial Report 2024: Achieved 30% Revenue Surge and Strong Profit Growth
HAIKOU, China, Dec. 6, 2024 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: JXJT) (the "Company"), a technology company engages in integrated tourism services, including tourism, duty-free cross-border goods, and comprehensive e-commerce technology solutions, today announced financial results for ...
Why Micro-LED Defines the Future of AR Glasses
SHENZHEN, China, Dec. 6, 2024 /PRNewswire/ -- VRTUOLUO, a new media platform focused on the VR/AR industry, has conducted an in-depth analysis of the AR glasses industry, shedding light on the technological advancements that are shaping its future. Here is the full article: Tech giants are in a ...
Hesai Announces Exclusive Lidar Design Win for Multiple Great Wall Motor Models
SHANGHAI, Dec. 6, 2024 /PRNewswire/ -- Today, Hesai Technology (NASDAQ: HSAI), the global leader in lidar solutions, announced an exclusive series production design win with Great Wall Motor, covering several models across its two brands. These models will feature Hesai's ATX, an ultra-compact hi...
Another star technology platform of the Sanyou AI-STAL family
——Introducing Sanyou Mrna Mab innovative antibody generation technology platform SHANGHAI, Dec. 6, 2024 /PRNewswire/ -- With the announcement of the 2024 Nobel Prize in Physiology or Medicine, microRNA has once again become the focus of global attention. In the past 20 years, three Nobel Prizes h...
Hohem Celebrates 10 Years of Innovation in Smartphone and Camera Gimbals
SHENZHEN, China, Dec. 6, 2024 /PRNewswire/ -- Hohem
Week's Top Stories
Most Reposted
Star-Studded Sponsor Line-up Takes Centre Court at the Singapore Tennis Open 2025
[Picked up by 291 media titles]
2025-01-28 10:49Sephora Unveils Its First Film, "Beauty & Belonging" Celebrating Diversity and Authenticity
[Picked up by 288 media titles]
2025-01-24 08:00Dahua Technology Joins Hands with WWF to Expand Sustainability Efforts Globally
[Picked up by 270 media titles]
2025-01-24 12:15HZICC: Linping Manufacturing Goes Global to Promote City Brand
[Picked up by 266 media titles]
2025-01-24 22:59Sushui Tech to Launch New DMFC Products at Smart Energy Week, Tokyo 2025
[Picked up by 259 media titles]
2025-01-28 09:53